Cite
HARVARD Citation
Michels, G. et al. (n.d.). A blinded, randomized, placebo‐controlled trial of the safety of lokivetmab (ZTS‐00103289), a caninized anti‐canine IL‐31 monoclonal antibody in client‐owned dogs with atopic dermatitis. Veterinary dermatology. 27 (6), pp. 505-e136. [Online].